Clinical trials have lead the way to innovation in the medical industry for years now and have positively affected this industry. COVID has shaken up this industry and shifted focus to primarily defeating this pandemic the world is suffering. Do you think clinical trials will lead to COVID's demise? Let's take a look at this article.
Before March 2020, most people could never imagine a global pandemic that would shut whole countries down. We’d mostly forgotten the Spanish flu of the early 20th century, and we believed that we were advanced enough, medically, to handle anything that life threw at us.
Then life showed us that we were very, very wrong.
It’s been many months since we first encountered Covid 19, and we’re still trying to tread water and get ahead of this virus. No one can predict exactly when that will happen, and it seems like we’re going to be in this fight for the long haul.
But for all the bad news about the pandemic, there have been some bright spots, and the advances in clinical trials and how the pharmaceutical industry handles new diseases have been one of them.
The pharmaceutical industry, like any other that relies on intellectual property, has always carefully guarded information. Covid 19 turned that all on its head.
China released the virus sequencing in record time, and teams from all over the world sprang into Covid research almost without thought of economic and business factors. In the race to stop Covid, we were all allies, and instead of guarding information for years, we were sharing the results of research study programs almost as soon as they were written.
Governments funded foreign research programs. Researchers shared information about the groundbreaking mRNA technology that eventually brought us vaccines in record time.
The world has stepped up to the plate in ways that we have never imagined before, and it’s helped us to get where we are today. But of course, there’s still a way to go.
Working together helped to turn the theory of mRNA vaccines, which were being researched since earlier SARS and MERS epidemics first threatend us years ago into reality. But it’s what happened after the vaccines were created that is really remarkable.
Usually, clinical trials take many years to complete. There are long phases and an abundance of caution. But this time, we didn’t have time for that. So, in many cases, the trial phases that would have run consecutively were run concurrently. This compressed the long, drawn-out process into a much shorter time, and allowed us to have vaccines in arms in record time.
It wasn’t only vaccines though.
During Covid, clinical trials have often gone from the lab to the hospital.
The limited treatments that we thought might work against Covid were given unprecedented emergency authorization for real world use, and studies were run in the halls of hospitals around the world. Some worked, others were found to be potentially dangerous, but the method was always extraordinary.
No one knows how Covid will eventually end. Or if it will. Maybe it will just become another seasonal illness, like the flu.
But no matter what happens to the virus, the pharmaceutical industry will probably never be the same. There are new ways to do things, and new, groundbreaking options for preventing and treating diseases. It’s been a rough couple of years, but that might well be the light at the end of the tunnel.